| Filed | Form | Description | |
|---|---|---|---|
| 11/14/24 | SC 13G/A | PRENETICS GLOBAL LTD | → |
| 2/5/24 | SC 13G/A | SC 13G/A | → |
| 11/27/23 | SC 13G/A | SC 13G/A | → |
| 8/7/23 | SC 13D | SCHEDULE 13D | → |
| 7/25/23 | SC 13D/A | SCHEDULE 13D AMENDMENT NO. 2 | → |
| 3/27/23 | SC 13D/A | SCHEDULE 13D AMENDMENT NO. 1 | → |
| ↓ | |||
Prenetics (NASDAQ:PRE) is a health sciences company headquartered in Hong Kong, with a presence in the United States. It focuses on early detection, prevention, and treatment of diseases, particularly cancer.